Oncology diagnostics company NeoGenomics (NASDAQ:NEO) will report earnings before market open. Last quarter, it missed revenue expectations by 0.9%, reporting revenues of $181.3 million, up 10.2% year on year. Analysts expect revenue to grow 9.5% this quarter to $183.8 million, with adjusted earnings at $0.02 per share. Peers Quest and Elevance Health reported revenue growth of 13.2% and 11% respectively. Healthcare providers & services segment saw positive sentiment with share prices up 7.6% on average. NeoGenomics is up 38.9% over the last month. Analysts reconfirm estimates. NeoGenomics has missed revenue estimates three times in the last two years.

Read more at StockStory Media: NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect